Advertisement

Topics

PubMed Journals Articles About "Late John Mendlein Joins Reinventing Biotech Lineup April" RSS

18:29 EDT 23rd June 2017 | BioPortfolio

Late John Mendlein Joins Reinventing Biotech Lineup April PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Late John Mendlein Joins Reinventing Biotech Lineup April articles that have been published worldwide.

More Information about "Late John Mendlein Joins Reinventing Biotech Lineup April" on BioPortfolio

We have published hundreds of Late John Mendlein Joins Reinventing Biotech Lineup April news stories on BioPortfolio along with dozens of Late John Mendlein Joins Reinventing Biotech Lineup April Clinical Trials and PubMed Articles about Late John Mendlein Joins Reinventing Biotech Lineup April for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Late John Mendlein Joins Reinventing Biotech Lineup April Companies in our database. You can also find out about relevant Late John Mendlein Joins Reinventing Biotech Lineup April Drugs and Medications on this site too.

Showing "Late John Mendlein Joins Reinventing Biotech Lineup April" PubMed Articles 1–25 of 3,100+

Announcement: National Public Health Week - April 3-9, 2017.

CDC joins the American Public Health Association (APHA) in celebration of National Public Health Week, April 3-9, 2017. Since 1995, APHA has led the observance of National Public Health Week during the first full week of April. The week recognizes the impact of public health on the health of the nation. The 2017 observance focuses on making the United States the Healthiest Nation in One Generation by 2030 by spotlighting the importance of prevention, employing successful strategies for collaboration, and pr...


John Stuart Garrow 19 April 1929-22 June 2016.

Are multiple-trial experiments appropriate for eyewitness identification studies? Accuracy, choosing, and confidence across trials.

Eyewitness identification experiments typically involve a single trial: A participant views an event and subsequently makes a lineup decision. As compared to this single-trial paradigm, multiple-trial designs are more efficient, but significantly reduce ecological validity and may affect the strategies that participants use to make lineup decisions. We examined the effects of a number of forensically relevant variables (i.e., memory strength, type of disguise, degree of disguise, and lineup type) on eyewitn...


Distribution and Quantity of Sites of John Cunningham Virus Persistence in Immunologically Healthy Patients: Correlation With John Cunningham Virus Antibody and Urine John Cunningham Virus DNA.

Although seroepidemiological studies indicate that greater than 50% of the population has been infected with John Cunningham virus (JCV), the sites of JCV persistence remain incompletely characterized.

Undermining position effects in choices from arrays, with implications for police lineups.

Choices from arrays are often characterized by position effects, such as edge-aversion. We investigated position effects when participants attempted to pick a suspect from an array similar to a police photo lineup. A reanalysis of data from 2 large-scale field studies showed that choices made under realistic conditions-closely matching eyewitness identification decisions in police investigations-displayed edge-aversion and bias to choose from the top row (Study 1). In a series of experiments (Studies 2a-2c ...

Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.

St John's wort is a popular herbal remedy recommended by Traditional Chinese Medicine (TCM) practitioners and licensed and widely prescribed for depression in many European countries. However, conflicting data regarding its benefits and risks exist, and the last large meta-analysis on St John's wort use for depression was done in 2008, with no updated meta-analysis available.

Growth and development in late preterm infants: What can public policy do?

Pediatric Research accepted article preview online, 19 April 2017. doi:10.1038/pr.2017.62.

Off they go: Single-use Technology in Future Production BioTech 2016 Conference at ZHAW Waedenswil.

"Keep up with today's single-use technology standard but also remain one step ahead" - that could have been the motto of the BioTech 2016 conference at ZHAW Waedenswil on September 5 and 6, which brought together manufacturers, suppliers, users, regulatory specialists and representatives of organizations in this field to implement single-use devices all over the world. It was an effectiveness analysis of the trend to replace reusable equipment in production facilities with single-use components.

Social Capital is Associated With Late HIV Diagnosis: An Ecological Analysis.

Late HIV diagnosis is associated with higher medical costs, early mortality among individuals, and HIV transmission in the population. Even under optimal configurations of stable or declining HIV incidence and increase in HIV case findings, no change in proportion of late HIV diagnosis is projected after year 2019. We investigated the association among social capital, gender, and late HIV diagnosis.

John Adams - an outstanding career.

A distinguished nurse, teacher, researcher and historian, John Adams was educated at Aylesbury Grammar School and graduated from Selwyn College, Cambridge, with a degree in theological and religious studies.

A New Animal Model of Gastric Lymphomagenesis: APRIL Transgenic Mice Infected by Helicobacter Species.

APRIL is a member of the tumor necrosis factor cytokine family involved in the regulation of B-cell immunity. We present a study of the infection by Helicobacter species of transgenic (Tg) C57BL6 mice, ectopically expressing the human form of APRIL. Wild-type (WT) and APRIL Tg mice were infected with Helicobacter felis and Helicobacter pylori and compared with noninfected animals. Mice were euthanized 18 months after infection, and inflammatory responses and histologic alterations were analyzed. Flow cytome...

Acknowledgement to referees.

Orbital fibroblasts of Graves' orbitopathy stimulated with proinflammatory cytokines promote B cell survival by secreting BAFF.

The success of rituximab for the treatment of active Graves' orbitopathy (GO) suggests that B cells play a critical role in intraorbital inflammation. B cell activating factor (BAFF) and its homolog a proliferation-inducing ligand (APRIL) are critical for B cell survival. However, the contribution of BAFF/APRIL to GO remains unclear. We sought to determine the role of BAFF/APRIL in the orbits of GO, and found that BAFF was markedly upregulated, while APRIL was not. Additionally, cultured GO orbital fibrobla...

First-quarter biotech job picture.

Fresh from the biotech pipeline-2016.

Fourth-quarter biotech job picture.

Biotech gender gap.

US immigration order strikes against biotech.

Why axing TPP was a lost opportunity for biotech.

Structural molecular biology - a personal reflection on the occasion of John Kendrew's 100th birthday.

Here I discuss the development and future of structural molecular biology, concentrating on the eukaryotic transcription machinery, and reflecting on John Kendrew's legacy from a personal perspective.

Late Talkers: A Population-Based Study of Risk Factors and School Readiness Consequences.

This study was designed to (a) identify sociodemographic, pregnancy and birth, family health, and parenting and child care risk factors for being a late talker at 24 months of age; (b) determine whether late talkers continue to have low vocabulary at 48 months; and (c) investigate whether being a late talker plays a unique role in children's school readiness at 60 months.

Trump election sends aftershocks through biotech sector.

New York spreads the news with $1.15 billion biotech plan.

Gender tokenism and bias prevail in biotech boardrooms.

The will to live - breast cancer patients perceptions' of palliative chemotherapy.

For women with metastatic breast cancer, late lines of chemotherapy might be beneficial but also harmful. Ongoing chemotherapy late in life increase the risk of late or absent discussions of palliative care and access to symptom relief by other options than chemotherapy. Our aim was, therefore, to investigate breast cancer patients' motives, perceptions, and experiences of late lines of palliative oncologic treatment.


Quick Search
Advertisement